Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013:2013:851267.
doi: 10.1155/2013/851267. Epub 2013 Sep 1.

Antihyperglycemic effects of short term resveratrol supplementation in type 2 diabetic patients

Ali Movahed  1 , Iraj Nabipour, Xavier Lieben Louis, Sijo Joseph Thandapilly, Liping Yu, Mohammadreza Kalantarhormozi, Seyed Javad Rekabpour, Thomas Netticadan
Affiliations

Antihyperglycemic effects of short term resveratrol supplementation in type 2 diabetic patients

Ali Movahed et al. Evid Based Complement Alternat Med. 2013.

Abstract

The objective of this study was to examine the effectiveness of resveratrol in lowering blood glucose in the presence of standard antidiabetic treatment in patients with type 2 diabetes, in a randomized placebo-controlled double-blinded parallel clinical trial. A total of 66 subjects with type 2 diabetes were enrolled in this study and randomly assigned to intervention group which was supplemented with resveratrol at a dose 1 g/day for 45 days and control group which received placebo tablets. Body weight, blood pressure, fasting blood glucose, haemoglobin A1c, insulin, homeostatic assessments for insulin resistance, triglycerides, total cholesterol, low density lipoprotein, high density lipoprotein, and markers of liver and kidney damage were measured at baseline and after 45 days of resveratrol or placebo supplementation. Resveratrol treatment significantly decreased systolic blood pressure, fasting blood glucose, haemoglobin A1c, insulin, and insulin resistance, while HDL was significantly increased, when compared to their baseline levels. On the other hand, the placebo group had slightly increased fasting glucose and LDL when compared to their baseline levels. Liver and kidney function markers were unchanged in the intervention group. Overall, this study showed that resveratrol supplementation exerted strong antidiabetic effects in patients with type 2 diabetes.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Consort diagram of the human trial.
Figure 2
Figure 2
Summary of the effect of resveratrol supplementation in type 2 diabetic patients for 45 days.
See this image and copyright information in PMC

References

    1. Herman WH, Zimmet P. Type 2 diabetes: an epidemic requiring global attention and urgent action. Diabetes Care. 2012;35:943–944. - PMC - PubMed
    1. Lam DW, LeRoith D. The worldwide diabetes epidemic. Current Opinion in Endocrinology, Diabetes and Obesity. 2012;19(2):93–96. - PubMed
    1. Forbes JM, Cooper ME. Mechanisms of diabetic complications. Physiological Reviews. 2013;93:137–188. - PubMed
    1. Stolar M. Glycemic control and complications in type 2 diabetes mellitus. American Journal of Medicine. 2010;123:S3–S11. - PubMed
    1. Louis XL, Thandapilly SJ, MohanKumar SK, et al. Treatment with low-dose resveratrol reverses cardiac impairment in obese prone but not in obese resistant rats. Journal of Nutritional Biochemistry. 2012;23:1163–1169. - PubMed